USE OF CARBAMATE COMPOUND FOR PREVENTION, RELIEF, OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY OR PERIPHERAL NEUROPATHY INDUCED BY CHEMOTHERAPY Russian patent published in 2022 - IPC A61K31/41 A61P25/02 

FIELD: pharmaceutics; medicine.

SUBSTANCE: object 1 is a method for prevention, relief, or treatment of diabetic peripheral neuropathy or peripheral neuropathy induced by chemotherapy in a subject, including administration to the subject of therapeutically effective amount of a carbamate compound, which is (R)-1-(2-chlorphenyl)-2-tetrazole-2-ylethyl ester of carbamic acid, or its pharmaceutically acceptable salt, solvate, or hydrate. Object 2 is the use of a carbamate compound, which is (R)-1-(2-chlorphenyl)-2-tetrazole-2-ylethyl ester of carbamic acid, or its pharmaceutically acceptable salt, solvate, or hydrate for prevention, relief, or treatment of diabetic peripheral neuropathy or peripheral neuropathy induced by chemotherapy in a subject.

EFFECT: prevention, relief, or treatment of diabetic peripheral neuropathy or peripheral neuropathy induced by chemotherapy in a subject.

10 cl, 3 dwg, 2 ex